Profiles

Keywords
Last Name
Institution

Connection

Kern Singh to Bone Morphogenetic Protein 2

This is a "connection" page, showing publications Kern Singh has written about Bone Morphogenetic Protein 2.

 
Connection Strength
 
 
 
2.374
 
  1. Ahn J, Tabaraee E, Singh K. BMP-2-induced Neuroforaminal Bone Growth in the Setting of a Minimally Invasive Transforaminal Lumbar Interbody Fusion. J Spinal Disord Tech. 2015 Jun; 28(5):186-8.
    View in: PubMed
    Score: 0.577
  2. Nandyala SV, Marquez-Lara A, Fineberg SJ, Pelton M, Singh K. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion. Spine (Phila Pa 1976). 2014 Feb 01; 39(3):185-91.
    View in: PubMed
    Score: 0.526
  3. Singh K, Nandyala SV, Marquez-Lara A, Cha TD, Khan SN, Fineberg SJ, Pelton MA. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion. Spine J. 2013 Sep; 13(9):1118-25.
    View in: PubMed
    Score: 0.511
  4. Singh K, Dumonski M, Stanley T, Ponnappan R, Phillips FM. Repeat use of human recombinant bone morphogenetic protein-2 for second level lumbar arthrodesis. Spine (Phila Pa 1976). 2011 Feb 01; 36(3):192-6.
    View in: PubMed
    Score: 0.427
  5. Singh K, Massel DH, Mayo BC, Bohl DD, Long WW, Modi KD. Bone Morphogenetic Proteins in Lumbar Arthrodesis: What Is All the Debate About? Commentary on an article by Daniel C. Beachler, PhD, MHS, et al.: "Bone Morphogenetic Protein Use and Cancer Risk Among Patients Undergoing Lumbar Arthrodesis: A Case-Cohort Study Using the SEER-Medicare Database". J Bone Joint Surg Am. 2016 07 06; 98(13):e57.
    View in: PubMed
    Score: 0.156
  6. Singh K, Smucker JD, Ugbo JL, Tortolani PJ, Tsai L, Fei Q, Kuh S, Rumi M, Heller JG, Boden SD, Yoon ST. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin. Spine J. 2007 May-Jun; 7(3):326-31.
    View in: PubMed
    Score: 0.080
  7. Singh K, Smucker JD, Gill S, Boden SD. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech. 2006 Aug; 19(6):416-23.
    View in: PubMed
    Score: 0.078
  8. Smucker JD, Rhee JM, Singh K, Yoon ST, Heller JG. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine (Phila Pa 1976). 2006 Nov 15; 31(24):2813-9.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.